Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Luorunchang is a Traditional Chinese Medicine (TCM) hospital preparation developed by Jinan Children's Hospital, specifically formulated for the treatment of acute respiratory tract infections in pediatric patients. The preparation is an oral liquid that combines several herbal extracts, including *Siraitia grosvenorii* (Luohanguo), *Eriobotrya japonica* (Loquat leaf), *Platycodon grandiflorus*, and *Stemona sessilifolia*. Its therapeutic mechanism is based on TCM principles of clearing heat, moistening the lungs, and resolving phlegm to alleviate symptoms such as cough, bronchial congestion, and excessive mucus production. As a hospital-specific preparation (院内制剂) in China, it is approved for use within the developing hospital and its affiliated medical network, serving as a standard treatment for acute bronchitis and related respiratory conditions in children.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Luorunchang.